-
admin
Posts
TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025
TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening TaiMed Biologics will reshape HIV treatment management and seeks strategic collaborations with global pharmaceutical...
FinVolution Group Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results
-Full Year 2024 Transaction Volume reached RMB206.2 billion, up 6.1% year-over-year- -Full Year 2024 International Transaction Volume exceeded RMB10.1 billion, up 27.8% year-over-year- -Full Year...
Outline Global Develops AI-Enabled Geospatial Mapping Platform with Oracle Database 23ai
Melbourne-based aerial intelligence firm leverages Oracle AI Vector Search to deliver data-intensive geospatial insights for its Australian clients. Harnesses the power of AI to increase revenue...
K&F CONCEPT Shines at CP+ 2025, Unveiling Boundless Imaging Possibilities
SHENZHEN, China, March 17, 2025 (GLOBE NEWSWIRE) — From February 27 to March 2, 2025, the globally renowned CP+ 2025 (Camera & Photo Imaging Show)...
HKTB Launches “Four Corners of Hong Kong” Video Series Inviting Visitors to Explore the Four Points of the Compass in Hong Kong
Highlighting Star-Studded Adventures on Mountain Trails and Coastal Islands to Inspire Visitors to Engage in In-Depth Green Travel HONG KONG, March 17, 2025 (GLOBE NEWSWIRE)...
Vitamin Patches Market Report 2025-2030, with Profiles of PatchMD, PatchAid, TheVitCo, B12Plast, Nutri-Patch, VitaPatch, Veru Wellness, Friendly Patch Co, Vita Sciences & Barriere
Dublin, March 17, 2025 (GLOBE NEWSWIRE) — The “Vitamin Patches Market Size, Share & Trends Analysis Report by Product (Vitamin D Patches, Vitamin C Patches),...
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development...
Tiziana Life Sciences to Present at the 37th Annual Roth Conference
NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies...
Bitterroot Bio to Present Detailed Results from Phase 1 Study of BRB-002 at American College of Cardiology Annual Scientific Session 2025
PALO ALTO, Calif. and NEEDHAM, Mass., March 17, 2025 (GLOBE NEWSWIRE) — Bitterroot Bio, a leader in developing innovative medicines in the field of cardio-immunology, announced...
MBX Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025 MBX 1416 Phase 2 trial in patients...
